1. Home
  2. EEIQ vs ALZN Comparison

EEIQ vs ALZN Comparison

Compare EEIQ & ALZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo EpicQuest Education Group International Limited

EEIQ

EpicQuest Education Group International Limited

HOLD

Current Price

$0.34

Market Cap

8.1M

Sector

Real Estate

ML Signal

HOLD

Logo Alzamend Neuro Inc.

ALZN

Alzamend Neuro Inc.

HOLD

Current Price

$2.21

Market Cap

9.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EEIQ
ALZN
Founded
2017
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Medicinal Chemicals and Botanical Products
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.1M
9.0M
IPO Year
2021
2021

Fundamental Metrics

Financial Performance
Metric
EEIQ
ALZN
Price
$0.34
$2.21
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$42.00
AVG Volume (30 Days)
66.8K
98.5K
Earning Date
08-21-2025
12-11-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$9,358,301.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
44.99
N/A
52 Week Low
$0.23
$1.88
52 Week High
$1.74
$12.06

Technical Indicators

Market Signals
Indicator
EEIQ
ALZN
Relative Strength Index (RSI) 44.12 49.49
Support Level $0.31 $2.03
Resistance Level $0.35 $2.35
Average True Range (ATR) 0.03 0.18
MACD 0.01 0.01
Stochastic Oscillator 84.23 51.47

Price Performance

Historical Comparison
EEIQ
ALZN

About EEIQ EpicQuest Education Group International Limited

EpicQuest Education Group International Ltd provides comprehensive education solutions for domestic and international students interested in university and college degree programs in the U.S., Canada, and the UK. In addition, the company has a recruiting relationship with the regional campuses of Miami University of Ohio, where it maintains residential facilities, a full-service cafeteria, recreational facilities, shuttle buses, and an office for the regional campuses that provides study abroad and post-study services for its students; these facilities are not owned, maintained, operated or are part of Miami University. Company operated in three primary reportable segments foreign language education (QHI), foreign language education (RIL) and the professional training programs.

About ALZN Alzamend Neuro Inc.

Alzamend Neuro Inc is an early clinical-stage biopharmaceutical company. It is focused on developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders, including Alzheimer's. Its mission is to develop and market safe and effective treatments. The company's pipeline consists of two novel therapeutic drug candidates, AL001 - a patented ionic cocrystal technology delivering lithium via a therapeutic combination of lithium, proline and salicylate, and AL002 - a patented method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine that seeks to restore the ability of a patient's immunological system to combat Alzheimer's.

Share on Social Networks: